news on tirzepatide drug fast-tracked for weight loss indication by FDA: What to know about it when was tirzepatide approved https://investor.lilly.com/news-releases/news-release-details/zepbound-

Excessive growth hormone can lead to side effects such as joint pain, swelling, insulin resistance, and injection site reactions

There has been significant research in recent years focused on the other potential benefits of GLP-1 analogues, many of which could be due to the impact they have on body mass index (BMI) and obesity

Staff have been really great throughout and also makes you feel at ease as they explain the procedures in depth and have an initial consultation to see how many and where it might be needed the most

This medication, initially developed for treating type 2 diabetes, has gained attention for its effectiveness in promoting weight loss

Our study fills a significant gap in the current understanding and management of patients on GLP-1 RAs undergoing surgery

Brunchmann et al